We have previously shown in MM that CD28 activation by itself transduces a major pro-survival/chemotherapy resistance signal [121,122], and others have shown that CD28 signaling in MM can decrease MM cell susceptibility to CD8 T cell-mediated anti-tumor immune responses [123]. The gene discussed is CD8A; the disease is Miyoshi myopathy.